PŘEHLEDOVÉ ČLÁNKY Systémová mastocytóza – společná diagnóza pro alergologa i hematologa 232 | VNITŘNÍ LÉKAŘSTVÍ / Vnitř Lék. 2024;70(4):224-232 / www.casopisvnitrnilekarstvi.cz 10. Patel J, Chang ChF, et al. Pulmonary involvement of systemic mastocytosis. Chest 2016;149(4): A468. Dostupné z: https://doi.org/10.1016/j.chest.2016. 02. 487. 11. Carvalhosa A, Damaj G, Canioni D, et al. Mast Cell Disease and Blood Coagulation Abnormalities: Discussion on 14 Cases and Review of the Literature. Blood. 2014;124:2856. Available from: https://doi.org/10.1182/blood.V124. 21. 2856.2856. 12. Valent P, Akin C, Hartmann K, et al. Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal. HemaSphere. 2021;5:11. ISSN 2572-9241. Available from: https://doi.org/10.1097/HS9.0000000000000646. 13. Pardanani A. Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management. American Journal of Hematology. 2023;98(7):1097-1116. ISSN 03618609. Available from: https://doi.org/10.1002/ajh.26962. 14. Lim KH, Tefferi A, Lasho TL, et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009;113:5727-5736. Available from: https://doi. org/10.1182/blood-2009-02-205237. 15. Zanelli M, Quintini M, Magnasco S, et al. Mast Cell Leukemia: An Update with a Practical Review. Cancers (Basel) 2023;15(6):1664. Available from: https://doi.org/10.3390/cancers15061664. 16. Gotlib J. Available and emerging therapies for bona fide advanced systemic mastocytosis and primary eosinophilic neoplasms. Hematology. 2022;1:34-46. ISSN 1520-4391. Available from: https://doi.org/10.1182/hematology.2022000368. 17. Cassassus P, Caillat-Vigneron N, Martin A, et al. Treatment of adult systemic mastocytosis with interferon-α: results of a multicentre phase II trial on 20 patients. Br J Haematol. 2002;119(4):1090-7. Available from: https://doi.org/10.1046/j.1365-2141.2002.03944.x. 18. Zhang LY, Smith ML, Schultheis B, et al. A novel K509I mutation identified in familial mastocytosis – in vitro and in vivo responsiveness to imatinib therapy. Leuk Res. 2006;30:373-378. Available from: https://doi.org/10.1016/j.leukres.2005. 08. 015. 19. Christen D, Lübke J, Kaiser A, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Advanced Systemic Mastocytosis. Blood. 2023; 142. (Suppl. 1): 3605. Available from: https://doi.org/10.1182/blood-2023-178304. 20. Valent P, Hartmann K, Bonadonna P, et al. Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium. The Journal of Allergy and Clinical Immunology: In Practice. 2022;10(8):1941-1950. ISSN 22132198. Available from: https://doi.org/10.1016/j.jaip.2022. 05. 007. 21. Monnier J, Georgin-Lavialle S, Canioni D, et al. Mast cell sarcoma: new cases and literature review. Oncotarget 2016; 7(40): 66299-66309. Available from: https://doi.org/10.18632/ oncotarget.11812. 22. Sandru F, Petca R-C, Costescu M, et al. Cutaneous Mastocytosis in Childhood – Update from the Literature. Journal of Clinical Medicine. 2021;10(7). Available from: https://doi. org/10.3390/jcm10071474. ODBORNÝ GARANT: doc. MUDr. Jaroslav Jeřábek, CSc. Neurootologické centrum 1. a 2. LF UK v Praze, FN Motol PARTNER KURZU POČET KREDITŮ 2 Registrace ZDARMA TERMÍN březen 2024 až únor 2025 dostupný na online.solen.cz ODBORNÝ PROGRAM Pacient s akutní závratí v ordinaci praktického lékaře doc. MUDr. Jaroslav Jeřábek, CSc. Klinické vyšetření pacienta se závratí – doporučený postup MUDr. Michaela Danková Polohové závratě – diagnostika a léčba – doc. PhDr. Ondřej Čakrt, Ph.D. Praktická část: Demonstrace základního vyšetření závrativého pacienta a nácvik polohových manévrů BPPV MUDr. Michaela Danková, doc. PhDr. Ondřej Čakrt, Ph.D. 52024 ON LINE KURZ On-line kurz Závratě
RkJQdWJsaXNoZXIy NDA4Mjc=